Responses
Regular and young investigator award abstracts
Cellular therapies
102 Cord-blood derived NK cells, and CAR-T cells, an attractive improved immunotherapy treatment to be considered for hematological malignancies
Compose a Response to This Article
Other responses
No responses have been published for this article.
